Fabrazyme and dyspnoea 
Fabrazyme and dyspnoea Patient Reports February 11, 2012
Fabrazyme Side Effects Report #6071380-9
Fabrazyme side effect was reported by a Physician from UNITED STATES on Jan 28, 2009. Female patient, 74 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, pleurisy, pneumonia
. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5264444-0
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Mar 05, 2007. Female patient, 63 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anxiety
, arthralgia, bradyarrhythmia, chest pain , chills, dizziness , dyspnoea, headache , hyperlipidaemia. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with ASPIRIN, LIPITOR, COLACE, LASIX, COZAAR, POTASSIUM CHLORIDE ER, SENOKOT, VERAPAMIL. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4863016-7
Fabrazyme side effect was reported by a Physician from GREECE on Aug 25, 2005. Male patient, 62 years of age, was diagnosed with fabry's disease, depression
, dementia alzheimer's type and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: asthenia, confusional state, depression , dizziness , dyspnoea, gait disturbance, hyperhidrosis, tachycardia. Fabrazyme dosage: 70 MG IV. During the same period patient was treated with RISPERDAL, REMERON, ARICEPT. Patient recovered.Fabrazyme Side Effects Report #5035555-X
Fabrazyme side effect was reported by a Physician from GREECE on Feb 08, 2006. Male patient, 62 years of age, was diagnosed with fabry's disease, depression
and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: asthenia, confusional state, dementia alzheimer's type, depression , dizziness , dyspnoea, gait disturbance, hyperhidrosis, tachycardia. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with REMERON. Patient recovered.Fabrazyme Side Effects Report #5788407-1
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on June 11, 2008. Female patient, 60 years of age, weighting 124.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac disorder, colon adenoma, colonic polyp
, dizziness , dyspnoea, gastric polyps, gastritis, gastrointestinal haemorrhage, gastrointestinal tract adenoma. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with SYNTHROID, DIGOXIN, COZAAR, LISINOPRIL, AMIODARONE, COUMADIN, FOSAMAX, FERROUS SULPHATE. Patient was hospitalized. Patient died on 05/26/2008.Fabrazyme Side Effects Report #5810184-6
Fabrazyme side effect was reported by a Physician from ITALY on June 26, 2008. Male patient, child 6 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: diarrhoea, dyspnoea, erythema, headache
, petechiae, pyrexia, swelling face, tremor, vomiting. Fabrazyme dosage: 1 MG/KG, QOW, INTRAVENOUS. Patient recovered.Fabrazyme Side Effects Report #4565622-6
Fabrazyme side effect was reported by a Health Professional from on Jan 14, 2005. Male patient, 58 years of age, weighting 164.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac disorder, condition aggravated, dyspnoea, nocturnal dyspnoea, oedema peripheral. Fabrazyme dosage: 70 MG Q2WKS, IV. During the same period patient was treated with CELLCEPT, BACTRIM, NEORAL, COUMADIN, LASIX. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5376648-7
Fabrazyme side effect was reported by a Physician from CANADA on June 15, 2007. Male patient, 56 years of age, weighting 148.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: acute myocardial infarction, anaemia, aortic valve incompetence, arrhythmia
, atrial fibrillation , bundle branch block left, bundle branch block right, dyspnoea, electrocardiogram st-t change. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with PLAVIX, HYDROCHLOROTHIAZIDE, COUMADIN, METOPROLOL SUCCINATE, NITROGLYCERIN, LIPITOR MFR, MONOCOR, ALTACE. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5872415-6
Fabrazyme side effect was reported by a Physician from GERMANY on Aug 19, 2008. Male patient, 56 years of age, weighting 180.8 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal discomfort, blood pressure fluctuation, dyspnoea, implantable defibrillator insertion, psychomotor skills impaired, tachycardia. Fabrazyme dosage: 75 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE. Patient was hospitalized and became disabled. Patient recovered.
Fabrazyme Side Effects Report #5903363-0
Fabrazyme side effect was reported by a Physician from GERMANY on Sept 12, 2008. Male patient, 56 years of age, weighting 180.8 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal discomfort, blood pressure fluctuation, dyspnoea, psychomotor skills impaired, tachycardia. Fabrazyme dosage: 75 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, OLMETEC. Patient was hospitalized and became disabled. Patient recovered.
Fabrazyme Side Effects Report #5930345-5
Fabrazyme side effect was reported by a Physician from GERMANY on Oct 10, 2008. Male patient, 56 years of age, weighting 180.8 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal discomfort, blood pressure fluctuation, disease progression, dyspnoea, epigastric discomfort, psychomotor skills impaired, tachycardia. Fabrazyme dosage: 75 MG,Q2W,INTRAVENOUS. During the same period patient was treated with ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, OLMETEC. Patient was hospitalized and became disabled. Patient recovered.
Fabrazyme Side Effects Report #4850967-2
Fabrazyme side effect was reported by a Health Professional from UNITED KINGDOM on Oct 20, 2005. Male patient, 56 years of age, weighting 134.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cough, dyspnoea, nasopharyngitis, oxygen saturation decreased, tachycardia, wheezing. Fabrazyme dosage: 60 MG Q2WKS IV. During the same period patient was treated with WARFARIN, DIGOXIN, BUMETANIDE. Patient recovered.
Fabrazyme Side Effects Report #5839403-7
Fabrazyme side effect was reported by a Physician from FRANCE on July 23, 2008. Male patient, 55 years of age, weighting 110.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, chills, dyspnoea, hypertension, hypoglycaemia, hypotension, hypoxia, livedo reticularis, nausea
. Fabrazyme dosage: 54 MG, INTRAVENOUS. Patient recovered.Fabrazyme Side Effects Report #4571923-8
Fabrazyme side effect was reported by a Physician from on Jan 19, 2005. Male patient, 55 years of age, weighting 155.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: aggression, aortic embolus, cardiomegaly, cerebrovascular accident, coronary artery disease
, disorientation, dyspnoea, ejection fraction decreased, headache . Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient died on 01/06/2005.Fabrazyme Side Effects Report #5010367-1
Fabrazyme side effect was reported by a Physician from UNITED STATES on Dec 09, 2005. Female patient, 55 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: arthropathy, cardiac disorder, dyspnoea, ejection fraction decreased, fluid overload, haemodialysis, treatment noncompliance. Fabrazyme dosage: unknown. Patient was hospitalized. Patient died on 12/01/2005.
Fabrazyme Side Effects Report #5377930-X
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2007. Male patient, 54 years of age, weighting 160.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: atrial fibrillation
, dyspnoea, international normalised ratio increased, oedema peripheral, pneumonia , tooth disorder , urinary tract infection , ventricular tachycardia. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4708979-5
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on June 22, 2005. Male patient, 54 years of age, weighting 150.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: apnoea, atrial fibrillation
, dizziness , dyspnoea, eye rolling, infusion related reaction, pulse absent, skin discolouration, somnolence. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with TOPROL, COZAAR, ASPIRIN, LIPITOR, GENGRAF, ENALAPRIL MALEATE, CELLCEPT, PREDNISONE. Patient recovered.Fabrazyme Side Effects Report #4751037-4
Fabrazyme side effect was reported by a Physician from UNITED STATES on Aug 08, 2005. Male patient, 54 years of age, weighting 169.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chills, dyspnoea, fall
, haematoma, hyperhidrosis, hypotension, hypoxia, oedema peripheral, pallor. Fabrazyme dosage: 76.8 MG Q2WKS IV. During the same period patient was treated with LEVAQUIN, CLEOCIN, NEORAL, CELLCEPT, PREDNISONE, LASIX, COUMADIN, LANOXIN. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4753882-8
Fabrazyme side effect was reported by a Physician from UNITED STATES on Aug 22, 2005. Male patient, 54 years of age, weighting 169.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chills, dyspnoea, fall
, haematoma, hyperhidrosis, hypotension, hypoxia, oedema peripheral, pallor. Fabrazyme dosage: 76.8 MG Q2WKS IV. During the same period patient was treated with LEVAQUIN, CLEOCIN, NEORAL, CELLCEPT, PREDNISONE, LASIX, COUMADIN, LANOXIN. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5375550-4
Fabrazyme side effect was reported by a Physician from COLOMBIA on Apr 28, 2007. Male patient, 53 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abnormal behaviour, discomfort, dyspnoea, hypertension, infusion related reaction. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with METOPROLOL SUCCINATE, CALCIUM CHLORIDE, OMEPRAZOLE, EPOGEN. Patient recovered.
Fabrazyme Side Effects Report #5117929-1
Fabrazyme side effect was reported by a Physician from COLOMBIA on Sept 12, 2006. Male patient, 53 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abnormal behaviour, agitation, dyspnoea, hypertension, infusion related reaction. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with CALCIUM GLUCONATE, OMEPRAZOLE, EPOGEN, METOPROLOL TARTRATE. Patient recovered.
Fabrazyme Side Effects Report #5905988-5
Fabrazyme side effect was reported by a Health Professional from AUSTRALIA on Sept 16, 2008. Female patient, 53 years of age, weighting 295.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, fluid overload, lower respiratory tract infection, oedema peripheral. Fabrazyme dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, LASIX, PERINDOPRIL ERBUMINE, NEXIUM, SPIRIVA, VENTOLIN, MICARDIS, NITRODERM. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4681194-X
Fabrazyme side effect was reported by a Health Professional from on May 18, 2005. Male patient, 53 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: atrial fibrillation
, dyspnoea. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with VICODIN, PERCOCET, CYCLOSPORINE, IMURAN, PREDNISONE, ASPIRIN, COUMADIN, ACIPHEX. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5227292-3
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 17, 2007. Female patient, 52 years of age, weighting 134.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chest pain
, dilatation ventricular, disease recurrence, dyspnoea, infusion related reaction, pulmonary arterial pressure increased, renal failure, renal transplant, weight decreased. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with TACROLIMUS, VALGANCICLOVIR, NPH INSULIN, SEPTRA, GABAPENTIN, LISPRO, LORATADINE. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4608319-6
Fabrazyme side effect was reported by a Physician from on Dec 08, 2004. Male patient, 52 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea, hypotension, nausea , paraesthesia. Fabrazyme dosage: 0.5 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5035813-9
Fabrazyme side effect was reported by a Physician from FRANCE on Apr 25, 2006. Male patient, 52 years of age, weighting 132.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: angina pectoris, asthenia, dyspnoea, malaise, pyrexia. Fabrazyme dosage: unknown. During the same period patient was treated with ASPIRIN, PRAVASTATIN, NITRODERM, TRIATEC, ACTONEL, CACIT D. Patient recovered.
Fabrazyme Side Effects Report #4850974-X
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 20, 2005. Male patient, 51 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, pharyngeal erythema, pharynx discomfort, rash
, rash pruritic. Fabrazyme dosage: 35 MG Q2WKS IV. During the same period patient was treated with BENADRYL, LORATADINE, STEROIDS. Patient recovered.Fabrazyme Side Effects Report #4907925-9
Fabrazyme side effect was reported by a Physician from JAPAN on Jan 31, 2006. Male patient, 49 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cough, dyspnoea, hypersensitivity, rales, wheezing. Fabrazyme dosage: 55 MG Q2WKS IV. During the same period patient was treated with PREDNISOLONE, HYDROXYZINE PAMOATE, IBUPROFEN. Patient recovered.
Fabrazyme Side Effects Report #4916429-9
Fabrazyme side effect was reported by a Physician from JAPAN on Feb 06, 2006. Male patient, 49 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cough, dyspnoea, hypersensitivity, infusion related reaction, rales, rash
, wheezing. Fabrazyme dosage: 55 MG Q2WKS IV. During the same period patient was treated with PREDNISOLONE, HYDROXYZINE PAMOATE, IBUPROFEN. Patient recovered.Fabrazyme Side Effects Report #4502472-0
Fabrazyme side effect was reported by a Health Professional from on Oct 27, 2007. Male patient, 48 years of age, weighting 141.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: body temperature increased, chest pain
, dry mouth, dyspnoea, heart rate increased, oral discomfort, oxygen saturation decreased, respiratory rate increased, skin discolouration. Fabrazyme dosage: 65 MG Q2WKS IV. During the same period patient was treated with PHENERGAN, ACETAMINOPHEN, ASPIRIN, FOLIC ACID, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5610435-7
Fabrazyme side effect was reported by a Physician from UNITED STATES on Jan 16, 2008. Male patient, 47 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: bladder disorder, bladder perforation, chest pain
, dyspnoea, fatigue, iatrogenic injury, post procedural complication, prostatic disorder. Fabrazyme dosage: 1 MG/KG, Q2W; INTRAVENOUS, 1 MG/KG, INTRAVENOUG. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5985304-3
Fabrazyme side effect was reported by a Physician from GREECE on Nov 20, 2008. Male patient, 47 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cyanosis, dyspnoea, pneumonia aspiration, pyrexia. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with MYOREL, EPREX, TEFRETOL, BEROVENT, PULMICORT. Patient died on 11/19/2008.
Fabrazyme Side Effects Report #4596193-6
Fabrazyme side effect was reported by a Physician from on Feb 21, 2005. Female patient, 47 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain
, condition aggravated, convulsion, dyspnoea, gastrointestinal disorder, hypertension, hypertensive crisis, treatment noncompliance, unevaluable event. Fabrazyme dosage: 1.1 MG/KG Q2WKS IV. During the same period patient was treated with WELLBUTRIN, NORVASC, CATAPRES, ATENOLOL. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5035482-8
Fabrazyme side effect was reported by a Physician from UNITED STATES on Mar 27, 2006. Male patient, 46 years of age, weighting 172.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood pressure decreased, chills, confusional state, cough, dyspnoea, lethargy, pallor, throat tightness. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with HYDROCORTISONE, BENADRYL, MAXZIDE, VICODIN. Patient recovered.
Fabrazyme Side Effects Report #5874645-6
Fabrazyme side effect was reported by a Physician from FRANCE on Aug 21, 2008. Male patient, 45 years of age, weighting 110.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, chills, dyspnoea, hypertension, hypoglycaemia, hypotension, hypoxia, livedo reticularis, nausea
. Fabrazyme dosage: 54 MG, INTRAVENOUS 0.5 MG/KG, INTRAVENOUS. Patient recovered.Fabrazyme Side Effects Report #5249168-8
Fabrazyme side effect was reported by a Physician from MEXICO on Feb 14, 2007. Male patient, 44 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, blood immunoglobulin g increased, cough, dry mouth, dyspnoea, hyperhidrosis, infusion related reaction, tachycardia, upper respiratory tract infection. Fabrazyme dosage: 70 MG/KG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, CARBAMAZEPINE, GABAPENTIN. Patient recovered.
Fabrazyme Side Effects Report #5306748-9
Fabrazyme side effect was reported by a Physician from MEXICO on Apr 10, 2007. Male patient, 44 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, blood immunoglobulin g increased, chills, cough, dry mouth, dyspnoea, hyperhidrosis, infusion related reaction, tachycardia. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with ENALAPRIL, CARBAMAZEPINE, GABAPENTIN. Patient recovered.
Fabrazyme Side Effects Report #5097557-7
Fabrazyme side effect was reported by a Physician from MEXICO on Aug 23, 2006. Male patient, 44 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chills, cough, dry mouth, dyspnoea, hyperhidrosis, infusion related reaction, tachycardia, tremor, wheezing. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with ENALAPRIL, CARBAMAZEPINE, GABAPENTIN. Patient recovered.
Fabrazyme Side Effects Report #5147003-X
Fabrazyme side effect was reported by a Physician from MEXICO on Oct 26, 2006. Male patient, 44 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chills, cough, dry mouth, dyspnoea, hyperhidrosis, infusion related reaction, tachycardia, tremor, wheezing. Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, CARBAMAZEPINE, GABAPENTIN. Patient recovered.
Fabrazyme Side Effects Report #4663698-9
Fabrazyme side effect was reported by a Health Professional from on May 12, 2005. Male patient, 44 years of age, weighting 135.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: angina pectoris, condition aggravated, dyspnoea, fabry's disease, headache
, heart rate increased, pain , shoulder pain, temperature regulation disorder. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with TEGRETOL, PREDNISONE, SANDIMMUNE, METOCLOPRAMIDE, ZOFRAN, XANAX, RESTORIL, PLENDIL. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5909605-X
Fabrazyme side effect was reported by a Health Professional from BRAZIL on Sept 19, 2008. Male patient, 43 years of age, weighting 110.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood pressure increased, dyspnoea, laryngospasm, malaise, pruritus, swollen tongue, tachycardia. Fabrazyme dosage: 70 MG; 35 MG. During the same period patient was treated with MORPHINE, ANTIHISTAMINES, ACETAMINOPHEN, ERYTHROPOIETIN, SEVELAMER, CALCIUM CARBONATE, DILITIAZEN, ASPIRIN. Patient recovered.
Fabrazyme Side Effects Report #5917808-3
Fabrazyme side effect was reported by a Health Professional from BRAZIL on Sept 30, 2008. Male patient, 43 years of age, weighting 110.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, laryngospasm, malaise, nausea
, pruritus, swollen tongue, tachycardia. Fabrazyme dosage: 70 MG,; 35 MG,. During the same period patient was treated with MORPHINE, ANTIHISTAMINES, ACETAMINOPHEN, ERYTHROPOIETIN, SEVELAMER, CALCIUM CARBONATE, DILITAZEN, ASPIRIN. Patient recovered.Fabrazyme Side Effects Report #6103117-9
Fabrazyme side effect was reported by a Health Professional from BRAZIL on Feb 18, 2009. Male patient, 43 years of age, weighting 110.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaphylactoid reaction, dyspnoea, heart rate increased, infusion related reaction, laryngospasm, malaise, nausea
, pruritus, respiratory rate increased. Fabrazyme dosage: 70 MG,; 35 MG,. During the same period patient was treated with MORPHINE, ANTIHISTAMINES, PARACETAMOL, ERYTHROPOIETIN, SEVELAMER, CALCIUM CARBONATE, DILTIAZEM, ASPIRIN. Patient recovered.Fabrazyme Side Effects Report #4652442-7
Fabrazyme side effect was reported by a Consumer or non-health professional from on Apr 18, 2005. Male patient, 43 years of age, weighting 123.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea, muscle strain. Fabrazyme dosage: 1 MG/KG, IV. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4696712-5
Fabrazyme side effect was reported by a Physician from on June 06, 2005. Male patient, 43 years of age, weighting 123.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: atelectasis, cardiac murmur, dyspnoea, muscle strain, musculoskeletal chest pain, productive cough, rhinorrhoea, scar
, sputum discoloured. Fabrazyme dosage: 1 MG/KG IV. During the same period patient was treated with PROGRAF, CELLCEPT, PREDNISONE, TOPROL, LIPITOR, ASPIRIN, GEMFIBROZIL. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5264141-1
Fabrazyme side effect was reported by a Physician from AUSTRALIA on Feb 28, 2007. Male patient, 39 years of age, weighting 143.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, periorbital oedema, swollen tongue. Fabrazyme dosage: 10 MG Q2WKS IV. During the same period patient was treated with HYDROCORTISONE, PHENERGAN, ZYRTEC, TRANSHEXAMIC A, ACETAMINOPHEN, DANAZOL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5264202-7
Fabrazyme side effect was reported by a Physician from AUSTRALIA on Feb 28, 2007. Male patient, 39 years of age, weighting 143.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, eye swelling, infusion related reaction, swollen tongue. Fabrazyme dosage: 35 MG Q2WKS IV. During the same period patient was treated with HYDROCORTISONE, ZYRTEC, ACETAMINOPHEN, DANAZOL, PROMETHAZINE, TRANSHEXAMIC ACID. Patient recovered.
Fabrazyme Side Effects Report #5108637-1
Fabrazyme side effect was reported by a Physician from AUSTRALIA on Sept 05, 2006. Male patient, 39 years of age, weighting 143.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, eye swelling, infusion related reaction, swollen tongue. Fabrazyme dosage: 10 MG Q2WKS IV. During the same period patient was treated with HYDROCORTISONE, PHENERGAN, ZYRTEC. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5189897-8
Fabrazyme side effect was reported by a Physician from AUSTRALIA on Sept 21, 2006. Male patient, 39 years of age, weighting 143.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, eye swelling, swollen tongue. Fabrazyme dosage: 35 MG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #4965966-X
Fabrazyme side effect was reported by a Physician from AUSTRALIA on Mar 21, 2006. Male patient, 39 years of age, weighting 143.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, eye swelling, infusion related reaction, swollen tongue. Fabrazyme dosage: 10 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4966124-5
Fabrazyme side effect was reported by a Physician from AUSTRALIA on Mar 21, 2006. Male patient, 39 years of age, weighting 143.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, eye swelling, swollen tongue. Fabrazyme dosage: 35 MG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #5738426-6
Fabrazyme side effect was reported by a Physician from UNITED STATES on Apr 29, 2008. Male patient, 38 years of age, weighting 205.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood immunoglobulin e increased, chest discomfort, dyspnoea, erythema, eye pruritus, eyelid oedema, rash maculo-papular, urticaria. Fabrazyme dosage: 90 MG, Q2W, INTRAVENOUS. During the same period patient was treated with LORAZEPAM, TOPAMAX, PROZAC, OXYCONTIN. Patient recovered.
Fabrazyme Side Effects Report #4658741-7
Fabrazyme side effect was reported by a Physician from on Apr 27, 2005. Male patient, 38 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: angina pectoris, blood pressure increased, chest pain
, dyspnoea, flushing, headache , infusion related reaction, pain in extremity, rash . Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with CLONIDINE, SANDIMMUNE. Patient recovered.Fabrazyme Side Effects Report #4680303-6
Fabrazyme side effect was reported by a Physician from on May 18, 2005. Male patient, 38 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: angina pectoris, blood pressure increased, dyspnoea, flushing, headache
, infusion related reaction, pain in extremity, rash , restlessness. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with CLONIDINE, SANDIMMUNE. Patient recovered.Fabrazyme Side Effects Report #4658735-1
Fabrazyme side effect was reported by a Physician from on Apr 27, 2005. Male patient, 37 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood pressure increased, chest pain
, dyspnoea, flushing, headache , infusion related reaction, pain in extremity. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with CLONIDINE, SANDIMMUNE. Patient recovered.Fabrazyme Side Effects Report #4680286-9
Fabrazyme side effect was reported by a Physician from on May 18, 2005. Male patient, 37 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood pressure increased, chest pain
, dyspnoea, flushing, headache , infusion related reaction, pain in extremity. Fabrazyme dosage: 70 MG Q2WK IV. During the same period patient was treated with CLONIDINE, SANDIMMUNE. Patient recovered.Fabrazyme Side Effects Report #4930459-2
Fabrazyme side effect was reported by a Physician from UNITED STATES on Feb 13, 2006. Female patient, 36 years of age, weighting 216.7 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, infusion related reaction, myocardial ischaemia, treatment noncompliance. Fabrazyme dosage: 1 MG/KG 2QWKS IV. During the same period patient was treated with AMITRIPTYLINE, TYLENOL W, OMEPRAZOLE, METHOCARBAMOL, ATENOLOL, LEXAPRO, DETROL LA. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4944163-8
Fabrazyme side effect was reported by a Physician from UNITED STATES on Feb 28, 2006. Female patient, 36 years of age, weighting 216.7 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chest pain
, dyspnoea, hypoperfusion, infusion related reaction, myocardial ischaemia, treatment noncompliance. Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with AMITRIPTYLINE, TYLENOL W, OMEPRAZOLE, METHOCARBAMOL, ATENOLOL, LEXAPRO, DETROL LA. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4997968-1
Fabrazyme side effect was reported by a Physician from UNITED STATES on Apr 24, 2006. Female patient, 36 years of age, weighting 216.7 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: back pain
, chest discomfort, dyspnoea, hypoperfusion, infusion related reaction, myocardial ischaemia, nausea , non-cardiac chest pain, pleuritic pain. Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with AMITRIPTYLINE, TYLENOL W, OMEPRAZOLE, METHOCARBAMOL, ATENOLOL, LEXAPRO, DETROL LA. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5776026-2
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on June 02, 2008. Male patient, 33 years of age, weighting 253.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure congestive, disease progression, dyspnoea, fabry's disease, haemodialysis, lymphoedema, pain
, pulmonary oedema, renal impairment. Fabrazyme dosage: 105 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ASPIRIN, DILANTIN, VALSARTAN, PHOSLO, FUROSEMIDE, CALCITRIOL. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4952178-9
Fabrazyme side effect was reported by a Physician from UNITED KINGDOM on Mar 07, 2006. Male patient, 31 years of age, weighting 149.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cough, dyspnoea, nasal congestion, peak expiratory flow rate abnormal, pruritus, syringomyelia
, wheezing. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with TEGRETOL, ACETAMINOPHEN, PIRITON. Patient was hospitalized and became disabled. Patient recovered.Fabrazyme Side Effects Report #5422305-8
Fabrazyme side effect was reported by a Physician from JAPAN on Aug 07, 2007. Male patient, 29 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chills, cyanosis, dyspnoea, oxygen saturation decreased, pyrexia, tremor. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with PREDNISONE, ENDARAVONE. Patient recovered.
Fabrazyme Side Effects Report #5166804-5
Fabrazyme side effect was reported by a Physician from ARGENTINA on Nov 16, 2006. Male patient, 28 years of age, weighting 103.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: asthenia, cardiovascular disorder, dyspnoea, malaise, sepsis
, staphylococcal bacteraemia, upper respiratory tract infection. Fabrazyme dosage: 50 MG IV. Patient died on 11/05/2006.Fabrazyme Side Effects Report #6140435-2
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2009. Male patient, 28 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cerebrovascular accident, chest discomfort, chest pain
, chills, dyspnoea, facial palsy, hyperhidrosis, impaired work ability, infusion related reaction. Fabrazyme dosage: 80 MG, INTRAVENOUS, 90 MG. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4607945-8
Fabrazyme side effect was reported by a Physician from on Nov 05, 2004. Male patient, 28 years of age, weighting 169.8 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain
, chest discomfort, chills, dyspnoea, ear infection , hypertension, myalgia, nausea , sinusitis . Fabrazyme dosage: 75 MG Q2WKS IV. During the same period patient was treated with LISINOPRIL, TYLENOL, VICODEN, PROTONIX, LEVID, ALLEGRA, HYDROXYZINE, ACETAMINOPHEN. Patient recovered.Fabrazyme Side Effects Report #5145653-8
Fabrazyme side effect was reported by a Physician from ARGENTINA on Oct 25, 2006. Male patient, 27 years of age, weighting 135.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: antibody test positive, dyspnoea, erythema, face oedema, fatigue, flushing, palpitations, paraesthesia. Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with IBUPROFEN, KETOROLAC TROMETHAMINE, LORATADINE, DEXAMETHASONE. Patient recovered.
Fabrazyme Side Effects Report #6037765-1
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 07, 2009. Male patient, 27 years of age, weighting 147.7 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal discomfort, anxiety
, bronchospasm, chest discomfort, chills, diarrhoea, dyspnoea, erythema, hyperhidrosis. Fabrazyme dosage: unknown. During the same period patient was treated with BENADRYL, ACETAMINOPHEN, PERCOCET. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4682115-6
Fabrazyme side effect was reported by a Physician from on Mar 17, 2005. Male patient, 27 years of age, weighting 160.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain upper, blood pressure increased, dyspnoea, nausea
. Fabrazyme dosage: unknown. During the same period patient was treated with TEGRETOL, MINOXODYL, LOPRESSOR, NORVASC. Patient recovered.Fabrazyme Side Effects Report #4607663-6
Fabrazyme side effect was reported by a Health Professional from on Nov 08, 2004. Male patient, 24 years of age, weighting 127.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, erythema, feeling hot. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with BENADRYL, PREDNISONE, TYLENOL. Patient recovered.
Fabrazyme Side Effects Report #5159148-9
Fabrazyme side effect was reported by a Physician from GREECE on Nov 07, 2006. Male patient, 23 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood pressure decreased, dysphagia, dyspnoea, flushing, tachycardia. Fabrazyme dosage: 1 MG/KG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #5159149-0
Fabrazyme side effect was reported by a Physician from GREECE on Nov 07, 2006. Male patient, 23 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dysphagia, dyspnoea, flushing. Fabrazyme dosage: 1 MG/KG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #5165200-4
Fabrazyme side effect was reported by a Physician from GREECE on Nov 14, 2006. Male patient, 23 years of age, weighting 187.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dysphagia, dyspnoea, flushing, infusion related reaction. Fabrazyme dosage: 1 MG/KG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #5178319-9
Fabrazyme side effect was reported by a Physician from GREECE on Nov 29, 2006. Male patient, 23 years of age, weighting 187.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dysphagia, dyspnoea, flushing. Fabrazyme dosage: 1 MG/MK Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #4607650-8
Fabrazyme side effect was reported by a Health Professional from on Dec 14, 2004. Male patient, 23 years of age, weighting 127.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chest discomfort, chest pain
, dyspnoea, flushing, nausea . Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with BENADRYL, TYLENOL, ALBUTEROL. Patient recovered.Fabrazyme Side Effects Report #4890880-8
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 09, 2006. Female patient, 23 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: catheter related infection, chest discomfort, dyspnoea, pyrexia, staphylococcal infection
, vomiting. Fabrazyme dosage: unknown. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4899597-7
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2006. Female patient, 23 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: central line infection, chest discomfort, disease recurrence, dyspnoea, pyrexia, staphylococcal infection
, vomiting. Fabrazyme dosage: 55 MG Q2WKS IV. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4607616-8
Fabrazyme side effect was reported by a Consumer or non-health professional from on Jan 24, 2005. Female patient, 22 years of age, weighting 123.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chest discomfort, dizziness
, dyspnoea. Fabrazyme dosage: 55 MG Q2WKS IV. During the same period patient was treated with LEXAPRO, LORTAB, BENADRYL, TYLENOL. Patient recovered.Fabrazyme Side Effects Report #4685098-8
Fabrazyme side effect was reported by a Health Professional from on Feb 08, 2005. Female patient, 22 years of age, weighting 123.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chest discomfort, dizziness
, dyspnoea. Fabrazyme dosage: 55 MG Q2WKS IV. During the same period patient was treated with LEXAPRO, LORTAB, BENADRYL, TYLENOL. Patient recovered.Fabrazyme Side Effects Report #5671494-9
Fabrazyme side effect was reported by a Physician from UNITED KINGDOM on Feb 28, 2008. Male patient, 21 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, blood pressure decreased, chest discomfort, choking sensation, cyanosis, dizziness
, dyspnoea, feeling abnormal, infusion related reaction. Fabrazyme dosage: unknown. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5725293-X
Fabrazyme side effect was reported by a Physician from UNITED KINGDOM on Apr 15, 2008. Male patient, 21 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, blood pressure decreased, chest discomfort, chills, choking sensation, cyanosis, dizziness
, dyspnoea, feeling abnormal. Fabrazyme dosage: 70 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5891528-6
Fabrazyme side effect was reported by a Physician from UNITED KINGDOM on Sept 03, 2008. Male patient, 21 years of age, weighting 152.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, chest discomfort, chills, dyspnoea. Fabrazyme dosage: 70 MG, QOW, INTRAVENOUS. During the same period patient was treated with PARACETAMOL. Patient recovered.
Fabrazyme Side Effects Report #5891528-6
Fabrazyme side effect was reported by a Physician from UNITED KINGDOM on Sept 03, 2008. Male patient, 21 years of age, weighting 152.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, chest discomfort, chills, dyspnoea. Fabrazyme dosage: 70 MG, QOW, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, CHLORPHENTERMINE. Patient recovered.
Fabrazyme Side Effects Report #5122405-6
Fabrazyme side effect was reported by a Physician from UNITED STATES on Sept 21, 2006. Male patient, 20 years of age, weighting 138.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: anxiety
, arthralgia, auricular swelling, blood pressure increased, bronchospasm, chest pain , cough, dyspnoea, erythema. Fabrazyme dosage: 60 MG Q2WKS IV. During the same period patient was treated with BENADRYL, TYLENOL. Patient recovered.Fabrazyme Side Effects Report #5038203-8
Fabrazyme side effect was reported by a Physician from UNITED STATES on June 14, 2006. Male patient, 20 years of age, weighting 138.7 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: auricular swelling, blood pressure increased, bronchospasm, chest pain
, cough, dyspnoea, erythema, fatigue, heart rate increased. Fabrazyme dosage: 60 MG Q2WKS IV. During the same period patient was treated with BENADRYL, TYLENOL. Patient recovered.Fabrazyme Side Effects Report #5035801-2
Fabrazyme side effect was reported by a Health Professional from UNITED KINGDOM on Apr 28, 2006. Male patient, 18 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chills, dyspnoea, flushing. Fabrazyme dosage: 70 MG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #5035783-3
Fabrazyme side effect was reported by a Physician from ITALY on Apr 09, 2006. Male patient, 17 years of age, weighting 143.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: agitation, blood pressure decreased, dyspnoea, malaise, palpitations, urticaria. Fabrazyme dosage: 7 MG Q2WKS IV. During the same period patient was treated with HYDROCORTISONE, CHLORFENIRAMINE MALEATE. Patient recovered.
Fabrazyme Side Effects Report #6115918-1
Fabrazyme side effect was reported by a Physician from INDIA on Feb 28, 2009. Male patient, 16 years of age, weighting 66.14 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, eyelid oedema, infusion related reaction, urticaria. Fabrazyme dosage: 35 MG, Q2W, INTRAVENOUS. During the same period patient was treated with AVIL. Patient recovered.
Fabrazyme Side Effects Report #4964618-X
Fabrazyme side effect was reported by a Physician from JAPAN on Mar 22, 2006. Male patient, 16 years of age, weighting 85.98 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain
, anaphylactoid reaction, dyspnoea, flushing, nasal congestion, pallor, rhinorrhoea. Fabrazyme dosage: 40 MG Q2WKS IV. During the same period patient was treated with HYDROXYZINE PAMOATE, METHYLPREDNISOLONE SUCCINATE, CARBAMAZEPINE. Patient recovered.Fabrazyme Side Effects Report #5009239-8
Fabrazyme side effect was reported by a Physician from JAPAN on May 08, 2006. Male patient, 16 years of age, weighting 85.98 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain
, anaphylactic reaction, blood pressure diastolic decreased, dyspnoea, flushing, headache , nasal congestion, nausea , pallor. Fabrazyme dosage: 40 MG Q2WKS IV. During the same period patient was treated with HYDROXYZINE, METHYLPREDNISOLONE SUCCINATE, CARBAMAZEPINE. Patient recovered.Fabrazyme Side Effects Report #5466301-3
Fabrazyme side effect was reported by a Physician from JAPAN on Sept 06, 2007. Male patient, 13 years of age, weighting 88.18 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cyanosis, dyspnoea. Fabrazyme dosage: 35 MG Q2WKS IV. During the same period patient was treated with HYDROXYZINE, ACETAMINOPHEN, HYDROCORTISONE SUCCINATE, CARBAMAZEPINE, PRANLUKAST HYDRATE. Patient recovered.
Fabrazyme Side Effects Report #5474885-4
Fabrazyme side effect was reported by a Physician from JAPAN on Sept 18, 2007. Male patient, 13 years of age, weighting 88.18 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cyanosis, dyspnoea, oxygen saturation decreased. Fabrazyme dosage: 35 MG Q2WKS IV. During the same period patient was treated with HYDROXYZINE, ACETAMINOPHEN, HYDROCORTISONE SUCCINATE, CARBAMAZEPINE, PRANLUKAST HYDRATE. Patient recovered.
Fabrazyme Side Effects Report #5796849-3
Fabrazyme side effect was reported by a Physician from JAPAN on June 24, 2008. Male patient, 13 years of age, weighting 88.18 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood immunoglobulin e increased, cyanosis, dyspnoea, oxygen saturation decreased. Fabrazyme dosage: 35 MG, Q2W, INTRAVENOUS. During the same period patient was treated with HYDROXYZINE, ACETAMINOPHEN, HYDROCORTISONE SUCCINATE, CARBAMAZEPINE, PRANLUKAST HYDRATE. Patient recovered.
Fabrazyme Side Effects Report #5035434-8
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Feb 22, 2006. Male patient, 13 years of age, weighting 139.8 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea. Fabrazyme dosage: 63 MG Q2WKS IV. During the same period patient was treated with CLARITIN, IBUPROFEN, ACETAMINOPHEN, BENADRYL. Patient recovered.
Fabrazyme Side Effects Report #5115002-X
Fabrazyme side effect was reported by a Physician from UNITED STATES on Sept 11, 2006. Male patient, child 12 years of age, weighting 80.00 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood pressure increased, body temperature increased, chills, dyspnoea, erythema, eye oedema, fall
, feeling cold, headache . Fabrazyme dosage: 30 MG Q2WKS IV. During the same period patient was treated with BENADRYL, MOTRIN. Patient recovered.Fabrazyme Side Effects Report #5122094-0
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 04, 2006. Male patient, child 12 years of age, weighting 78.00 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: auricular swelling, convulsion, dyspnoea, eyelid oedema, heart rate increased, hypertension, infusion related reaction, swelling face. Fabrazyme dosage: 1MG/KILO OF BODY WEIGHT EVERY 14 DAYS IV. During the same period patient was treated with ANTIPYRETICS. Patient recovered.
Fabrazyme Side Effects Report #5132089-9
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2006. Male patient, child 12 years of age, weighting 80.00 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blood pressure diastolic decreased, blood pressure increased, body temperature decreased, body temperature increased, chills, dyspnoea, erythema, eye oedema, fall
. Fabrazyme dosage: 30 MG Q2WKS IV. During the same period patient was treated with BENADRYL, MOTRIN. Patient recovered.Fabrazyme Side Effects Report #4608013-1
Fabrazyme side effect was reported by a Consumer or non-health professional from on Jan 31, 2005. Male patient, child 10 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, erythema, fall
, swelling face. Fabrazyme dosage: unknown. Patient recovered.Fabrazyme Side Effects Report #4685095-2
Fabrazyme side effect was reported by a Physician from on Feb 16, 2005. Male patient, child 10 years of age, weighting 67.46 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dyspnoea, erythema, fall
, swelling face. Fabrazyme dosage: 32 MG Q2WKS IV. During the same period patient was treated with TYLENOL, BENADRYL. Patient recovered.Fabrazyme Side Effects Report #5605453-9
Fabrazyme side effect was reported by a Physician from POLAND on Jan 09, 2008. Male patient was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: amputation, bone density decreased, cardiac valve disease, chills, dyspnoea, extremity necrosis, heart valve incompetence, impaired healing, inflammation. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, STEROIDS, METHYLPREDNISOLONE, ACETAMINOPHEN, ACE INHIBITOR NOS, BETA BLOCKING AGENTS, STATIN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5760244-3
Fabrazyme side effect was reported by a Physician from POLAND on May 06, 2008. Male patient was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: aortic valve disease, aortic valve incompetence, cerebral calcification, chills, demyelination, dyspnoea, extremity necrosis, foot amputation, infusion related reaction. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, STEROIDS, METHYLPREDNISOLONE, ACETAMINOPHEN, ACE INHIBITOR NOS, BETA BLOCKING AGENTS, STATIN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5798663-1
Fabrazyme side effect was reported by a Pharmacist from UNITED KINGDOM on Oct 11, 2007. Male patient was diagnosed with fabry's disease, diarrhoea and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: blister, dyspnoea, hypersensitivity, rash
, swollen tongue. Fabrazyme dosage: 35 MG, INTRAVENOUS. During the same period patient was treated with ASPIRIN, CARBAMAZEPINE, SOTALOL, PROCYCLIDINE HYDROCHLORIDE, LANSOPRASOLE, NICORANDIL, LOPERAMIDE. Patient was hospitalized. Patient recovered.